coopaloop21. Thanks for posting your e-mail you sent to the
coopaloop21. Thanks for posting your e-mail you sent to the BOD.
I don't agree with the term "death spiral" or it's relevance at the very bottom end of the OTC market. There are countless stocks in the OTC that sit at no bid x .0001 or .0001 x .0002 that suddenly offer huge profits for those that are observant and react immediately in a decisive manner. Very often there are no catalysts just a few whales buying large amounts, others buying as a reaction to scanner alerts, followed by increased posting activity and pumped opinions based on tenuous links surrounding any minor change in circumstances.
I passed on 2 that started today because I was already concentrating on 2 from yesterday and the day before as well as all my medium and longer term plays concurrently. One of those went from a .0002 convertible debt dump to .0008 in a matter of hours offering the opportunity to either trade a large volume for one-tick or a more modest lotto for a high risk 5 ticks by the close.
With 5+ Billion REDG shares being bought by traders since July 1, that sort of thing could easily have happened with REDG - as it did in 2016 with 1.4B bought over the previous 7 months when nobody was paying attention on iHub.
Those common shares were bought for a reason and anyone who loaded more than 100M at .0001s will have a high share count that is much more tradable after a r/s - in that there are many more options in the .1 > .2 range rather than the only choice being .0001 commission loss or 100% at .0002.
Anyway, please post any response you might get from the BOD. I suspect that they have taken advice from the expert counsel / investor who specializes in raising capital (referred to in previous posts) before making their decision and I suspect that anyone who had the slightest clue that the r/s was going to happen has been adding .0001s to get their share count way up - so I do not imagine the decision will be reversed now (although other companies did - PKGM for instance in the recent past and now doing very well after being at rock bottom for some months).
Red Giant Entertainment Inc. (REDG) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...
Continue Reading
A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...
Continue Reading
Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...
Continue Reading
WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...
Continue Reading
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...
Continue Reading
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...
Continue Reading
When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...
Continue Reading
KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...
Continue Reading
Top 5 Most Recently Viewed Articles
Bertucci Investment Group: Celebrating Success Bertucci Investment Group, known for facilitating smooth property sales for cash, is excited to share its significant achievement of earning consistent five-star reviews on Google. This milestone highlights the company’s dedication to providing an efficient and trustworthy service for homeowners. A Commitment to Excellence...
Continue Reading
Current Mortgage Rate Trends The 30-year mortgage rate has recently fallen to 5.93%, indicating a positive shift in the market compared to previous rates. This change is significant, as refinancing rates have also decreased substantially. These developments present opportunities for both new homebuyers and those looking to refinance their current loans. Current Mortgage...
Continue Reading
Market Insights on Bitcoin's Challenges The narrative that Bitcoin operates as a safe haven during times of geopolitical tension has recently faced significant scrutiny. The leading cryptocurrency experienced a sharp decline, dropping below $62,000, amidst fears of escalating conflict in the Middle East. Bitcoin's Downturn As the situation escalated with reports of Iran's...
Continue Reading
A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....
Continue Reading
The Mortgage Market and Its Impacts Recent shifts in U.S. mortgage rates have created significant waves in the real estate sector. The 30-year fixed mortgage rate recently hit 7.79%—the highest it’s been since 2000. This surge poses challenges for homeowners, many of whom are hesitant to sell their properties, worried they might sacrifice their favorable lower rates....
Continue Reading